NASDAQ:PEPG

PepGen (PEPG) Stock Price, News & Analysis

$11.93
+0.23 (+1.97%)
(As of 04/26/2024 ET)
Today's Range
$11.26
$12.09
50-Day Range
$10.53
$17.30
52-Week Range
$3.72
$17.51
Volume
38,359 shs
Average Volume
54,154 shs
Market Capitalization
$385.94 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$24.67

PepGen MarketRank™ Stock Analysis

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
106.8% Upside
$24.67 Price Target
Short Interest
Healthy
1.25% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.75mentions of PepGen in the last 14 days
Based on 3 Articles This Week
Insider Trading
Acquiring Shares
$27.21 M Bought Last Quarter
Proj. Earnings Growth
Growing
From ($2.88) to ($2.74) Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

3.31 out of 5 stars

Medical Sector

309th out of 913 stocks

Pharmaceutical Preparations Industry

141st out of 420 stocks

PEPG stock logo

About PepGen Stock (NASDAQ:PEPG)

PepGen Inc., a clinical-stage biotechnology company, focuses on the development of oligonucleotide therapeutics for use in the treatment of severe neuromuscular and neurologic diseases. Its lead product candidate is PGN-EDO51, an EDO peptide that is in Phase 2 clinical trial to treat Duchenne muscular dystrophy (DMD) patients. The company is also developing PGN-EDODM1, an EDO peptide-conjugated PMO, which is in Phase 1 clinical trial for the treatment of myotonic dystrophy type 1, as well as EDO therapeutic candidates, such as PGN-EDO53, PGN-EDO45, and PGN-EDO44 for the treatment of DMD. PepGen Inc. was founded in 2018 and is based in Boston, Massachusetts.

PEPG Stock Price History

PEPG Stock News Headlines

PepGen (NASDAQ:PEPG) Trading 8.1% Higher
Protect Yourself While There’s Still Time …
The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom.
PepGen to Participate in Upcoming Investor Conferences
Protect Yourself While There’s Still Time …
The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom.
Stifel Nicolaus Reaffirms Their Buy Rating on PepGen Inc. (PEPG)
PEPG Stock Earnings: PepGen Beats EPS for Q4 2023
PepGen Stock Higher After Follow-on Offering
Top 4 Health Care Stocks That May Crash This Quarter
See More Headlines
Receive PEPG Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for PepGen and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
3/06/2024
Today
4/26/2024
Next Earnings (Estimated)
5/09/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:PEPG
Fax
N/A
Employees
64
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$24.67
High Stock Price Target
$28.00
Low Stock Price Target
$20.00
Potential Upside/Downside
+106.8%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
2 Analysts

Profitability

Net Income
$-78,630,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Book Value
$4.55 per share

Miscellaneous

Free Float
31,070,000
Market Cap
$385.94 million
Optionable
Not Optionable
Beta
1.54
Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

Key Executives

  • Dr. James G. McArthur Ph.D. (Age 62)
    President, CEO, Treasurer, Secretary & Director
    Comp: $834.98k
  • Mr. Noel P. Donnelly M.B.A. (Age 54)
    Chief Financial Officer
    Comp: $650.17k
  • Mr. Niels Svenstrup Ph.D. (Age 54)
    Senior Vice President of Chemistry, Manufacturing & Control
    Comp: $455.15k
  • Dr. Michael Gait Ph.D.
    Founder & Scientific Advisory Board Member
  • Ms. Mary Beth DeLena
    General Counsel & Secretary
  • Dr. Michelle L. Mellion M.D. (Age 48)
    Senior VP & Head of Clinical Development
  • Ms. Emiko Bryant
    Chief of Staff
  • Mr. Kyle Breidenstine
    VP of Finance & Controller

PEPG Stock Analysis - Frequently Asked Questions

Should I buy or sell PepGen stock right now?

2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for PepGen in the last twelve months. There are currently 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" PEPG shares.
View PEPG analyst ratings
or view top-rated stocks.

What is PepGen's stock price target for 2024?

2 analysts have issued 12-month price targets for PepGen's shares. Their PEPG share price targets range from $20.00 to $28.00. On average, they predict the company's stock price to reach $24.67 in the next year. This suggests a possible upside of 106.8% from the stock's current price.
View analysts price targets for PEPG
or view top-rated stocks among Wall Street analysts.

How have PEPG shares performed in 2024?

PepGen's stock was trading at $6.80 at the beginning of the year. Since then, PEPG stock has increased by 75.4% and is now trading at $11.93.
View the best growth stocks for 2024 here
.

Are investors shorting PepGen?

PepGen saw a decline in short interest during the month of April. As of April 15th, there was short interest totaling 338,800 shares, a decline of 15.3% from the March 31st total of 400,200 shares. Based on an average daily trading volume, of 134,600 shares, the short-interest ratio is currently 2.5 days. Approximately 1.3% of the shares of the company are sold short.
View PepGen's Short Interest
.

When is PepGen's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, May 9th 2024.
View our PEPG earnings forecast
.

How were PepGen's earnings last quarter?

PepGen Inc. (NASDAQ:PEPG) posted its quarterly earnings data on Wednesday, March, 6th. The company reported ($0.82) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($1.01) by $0.19.

What ETFs hold PepGen's stock?

ETFs with the largest weight of PepGen (NASDAQ:PEPG) stock in their portfolio include Morningstar US Small Growth (MSGR).iShares Neuroscience and Healthcare ETF (IBRN).

When did PepGen IPO?

PepGen (PEPG) raised $126 million in an initial public offering (IPO) on Friday, May 6th 2022. The company issued 9,000,000 shares at a price of $13.00-$15.00 per share.

How do I buy shares of PepGen?

Shares of PEPG stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:PEPG) was last updated on 4/27/2024 by MarketBeat.com Staff

From Our Partners